Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
bacterial infections
India's Wockhardt Starts Global Phase 3 Study Of Its Super Drug 'WCK 5222' To Treat Antibiotic-Resistant Bacterial Infections
Swarajya Staff
Aug 16, 2022 08:56 AM +05:30 IST
COVID-19 Virus May Activate Dormant Bacterial Infections, Tuberculosis: Study
IANS
Jun 17, 2021 02:07 PM +05:30 IST
IISc Researchers Identify New Blood-Based Biomarker For Differential Diagnosis Of Bacterial, Viral Infections
IANS
May 18, 2021 10:30 AM +05:30 IST
Load More